T1	Participants 38 110	bipolar type II or bipolar NOS major depression - low manic switch rate.
T2	Participants 171 225	bipolar type II (BP II) major depressive episode (MDE)
T3	Participants 576 710	As part of a randomized, double-blind, placebo-controlled relapse-prevention study of fluoxetine monotherapy in BP II MDE, 37 patients
T4	Participants 1826 1836	BP II MDE.
